InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
6
Disclosed sells
1
T+90 hit rate
40%
T+90 mean return
+5.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Galluppi Stefan, Chief Technology Officer. Officer active across 2 companies, notably LifeMD, Inc.. Aggregated, 12 filings have been recorded. Breakdown: 6 buys · 1 sell. Total volume traded: €992k. Activity tracked since 19 May 2021. The latest transaction was disclosed on 22 August 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Galluppi Stefan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
30,000 shares0Common StockSEC:0000912282-25-000915:0
85,000 shares@ US$12.3842100.0% of flowCommon StockSEC:0000912282-25-000683:0
30,000 shares0Common StockSEC:0000912282-25-000363:0
30,000 shares0Common StockSEC:0000912282-25-000282:0
60,000 shares0Common SharesSEC:0000912282-25-000265:0
3,000 shares@ US$4.9314.5% of flowCommon StockSEC:0001362118-24-000022:0
Canonical exit: 10 Dec 2024 (T+90)
30,000 shares0Common StockSEC:0001362118-24-000010:0
4,608 shares@ US$2.1710.0% of flowCommon Stock, par value $0.01SEC:0001362118-23-000035:0
Canonical exit: 21 Aug 2023 (T+90)
10,000 shares@ US$2.1721.7% of flowCommon Stock, par value $0.01SEC:0001362118-23-000032:0
Canonical exit: 21 Aug 2023 (T+90)
100 shares@ US$4.790.5% of flowCommon Stock, par value $0.01SEC:0001362118-21-000043:0
Canonical exit: 15 Feb 2022 (T+90)
2,097 shares@ US$4.559.9% of flowCommon Stock, par value $0.01SEC:0001362118-21-000042:0
Canonical exit: 13 Feb 2022 (T+90)
3,796 shares@ US$10.4038.6% of flowCommon Stock, par value $0.01SEC:0001362118-21-000014:0
Canonical exit: 17 Aug 2021 (T+90)
12 of 12 declarations
About Galluppi Stefan
Galluppi Stefan is Directeur Technique and Chief Innovation Officer at LifeMD, Inc. The 12 known filings span from 2021-05-21 to 2025-08-26. In the recent sampled filings of 12, purchases total EUR 84060 and sales total EUR 907443, and the modal transaction nature is Acquisition.
